“Barron’s Roundtable” is discussing drug demand, investment in Nike and Delta Airlines.
Weightwatches, Wellness program Once she was supported by Opera, she applied for bankruptcy this week to try to strengthen its financial position and ensure that it remains in the very saturated weight loss market.
When submitted for bankruptcy protection, Chapter 11, WW International Inc. said. It will be able to eliminate the debts of $ 1.15 billion in its public budget, and put itself for long -term growth and success.
“The decisive measures we take today, with tremendous support for our lending and caring notes, will give us flexibility in accelerating innovation, re -investing in our members, and leading power in the scene of rapid weight management,” said Tara Kuminte, CEO of Weightwatches.
Weightwatches is betting on weight loss medications with a new program launch
The company said that it will remain fully operating during this process and the members will not be affected. This means that “the plans they rely on to support weight management goals” will continue to work completely.
While she stopped trading on the Nasdak Stock Exchange, weightwatches expects to appear as a company circulating publicly when Complete the reorganization process.
The weight monitors are marked in the office in the lower Manhattan, New York 19 October 2015. (Reuters / Brendan McDdedide / Reuters)
The company started in the sixties and revolutionized the diet industry through weight loss and weight management programs. It even gained a revenge between the prominent figures with the Oprah partnership with the company in 2015. She left the board of directors in 2024.
Opera Winfrey left Weightwatches from May 2024. (Axelle/Bauer-Griffin/Filmagic/Fox News)
Sima Sistani CEO of Weightwatches in sudden exit, embraced weight loss medications
However, in recent years, the company has struggled to remain able to compete because the popularity of drugs that lose weight quickly changed how people deal with a diet.
Morgan Stanley Research has re -evaluated the global drug market, and is now expected to reach between 105 billion dollars and 144 billion dollars in 2030. This increases from a previous drop of $ 77 billion. In 2023, sales of obesity with brands with $ 6 billion, according to Morgan Stanley Research.
The company has struggled to stay competitive in recent years, as the popularity of weights that lose weight quickly changed how people deal with a diet. (Michael Nagle / Bloomberg via Getty Images / Getty Images)
In an attempt to revive the brand, the company captured the sequence of the health care platform, now known as the Weightwatches clinic, to help expand Obesity Medical prescriptions. Through a remote health care platform, it provides trained doctors on obesity, weight -loss medications, and virtual and personal workshops.
Get Fox Business on the Go by clicking here
However, the company’s problems continued as former CEO Sima Sistani suddenly left in September 2024.
https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2025/05/0/0/weightwatchers-1.jpg?ve=1&tl=1
Source link